open access

Vol 22, No 2 (2018)
ORIGINAL PAPERS
Published online: 2018-06-29
Get Citation

Acute myocardial infarction risk factors among population with premature cardiovascular disease

Agnieszka Maria Pura, Marta Wilk, Gabriela Kuczyńska, Klaudia Bielecka, Larysa Bielecka, Katarzyna Wąchała, Maria Olszowska
DOI: 10.5603/AH.2018.0008
·
Arterial Hypertension 2018;22(2):81-86.

open access

Vol 22, No 2 (2018)
ORIGINAL PAPERS
Published online: 2018-06-29

Abstract

ABSTRACT INTRODUCTION: Cardiovascular diseases (CVDs) are the main cause of death worldwide. In the last 40 years we can observe increase in prevalence of CVDs among young population. [1] Control of risk factors is especially important in young group of patients because the long-term prognosis for this group is particularly unfavorable.[2] MATERIALS AND METHODS: 100 medical records of following patients hospitalized between 2014 - 2017 in Department of Cardiac and Vascular Diseases in Cracow Specialist Hospital were analyzed with special attention to myocardial infarction risk factors. The study included 58 women under the age of 55 and 42 men under 45 divided into two groups with or without acute coronary syndrome (ACS). RESULTS: 86% of examined population had LDL level higher than 1,8 mmol/l, 65% smoked cigarettes and 86,4% had thickened intima-media complex. HDL level was below the norm in 47,4% of the group with ACS and only in 20,9% of the group without ACS (p < 0,05). Significant differences between groups in combined risk factors were observed in decreased HDL level accompanied by increased LDL (40,4% with ACS, 20,9% without ACS), tobacco abuse (38,6% with ACS, 18,6% without ACS) or arterial hypertension (40,4% with ACS, 18,6% without ACS). CONCLUSION: The most important risk factor of acute myocardial infarction in the studied group with early onset of CVD was reduced HDL level.

Abstract

ABSTRACT INTRODUCTION: Cardiovascular diseases (CVDs) are the main cause of death worldwide. In the last 40 years we can observe increase in prevalence of CVDs among young population. [1] Control of risk factors is especially important in young group of patients because the long-term prognosis for this group is particularly unfavorable.[2] MATERIALS AND METHODS: 100 medical records of following patients hospitalized between 2014 - 2017 in Department of Cardiac and Vascular Diseases in Cracow Specialist Hospital were analyzed with special attention to myocardial infarction risk factors. The study included 58 women under the age of 55 and 42 men under 45 divided into two groups with or without acute coronary syndrome (ACS). RESULTS: 86% of examined population had LDL level higher than 1,8 mmol/l, 65% smoked cigarettes and 86,4% had thickened intima-media complex. HDL level was below the norm in 47,4% of the group with ACS and only in 20,9% of the group without ACS (p < 0,05). Significant differences between groups in combined risk factors were observed in decreased HDL level accompanied by increased LDL (40,4% with ACS, 20,9% without ACS), tobacco abuse (38,6% with ACS, 18,6% without ACS) or arterial hypertension (40,4% with ACS, 18,6% without ACS). CONCLUSION: The most important risk factor of acute myocardial infarction in the studied group with early onset of CVD was reduced HDL level.
Get Citation

Keywords

risk factors, premature cardiovascular disease, acute myocardial infarction

About this article
Title

Acute myocardial infarction risk factors among population with premature cardiovascular disease

Journal

Arterial Hypertension

Issue

Vol 22, No 2 (2018)

Pages

81-86

Published online

2018-06-29

DOI

10.5603/AH.2018.0008

Bibliographic record

Arterial Hypertension 2018;22(2):81-86.

Keywords

risk factors
premature cardiovascular disease
acute myocardial infarction

Authors

Agnieszka Maria Pura
Marta Wilk
Gabriela Kuczyńska
Klaudia Bielecka
Larysa Bielecka
Katarzyna Wąchała
Maria Olszowska

References (16)
  1. Stan zdrowia ludności Polski w 2004 roku. http://www.stat.gov.pl/gus (05.05.2018).
  2. Maroszyńska-Dmoch EM, Wożakowska-Kapłon B. Choroba wieńcowa w populacji młodych dorosłych: skala problemu, czynniki ryzyka i rokowanie — przegląd literatury. Folia Cardiologica. 2014; 9(3): 267–274.
  3. Cardiovascular disease — key facts. http://www.who.int/cardiovascular_diseases/en/ (05.05.2018).
  4. Global Health Observatory (GHO) data. Top 10 causes of death, situation and trends. http://origin.who.int/gho/mortality_burden_disease/causes_death/top_10/en/ (05.05.2018).
  5. Hannah Ritchie and Max Roser (2018) — Causes of Death. https://ourworldindata.org/causes-of-death (05.05.2018).
  6. Program Profilaktyki i Leczenia Chorób Układu Sercowo-Naczyniowego POLKARD. https://www.gov.pl/zdrowie/program-profilaktyki-i-leczenia-chorob-ukladu-sercowo-naczyniowego-polkard-na-lata-2017-2020 (05.05.2018).
  7. Ostrówka D, Jancewicz M, Komand A, et al. Awareness of the role of cardiovascular risk factors and their prevention from the perspective of Tricity adolescents. Arterial Hypertension. 2017; 21(1): 51–59.
  8. Piepoli MF, Hoes AW, Agewall S, et al. ESC Scientific Document Group. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016; 37(29): 2315–2381.
  9. Tykarski A, Narkiewicz K, Gaciong Z, et al. Guidelines for the Management of Hypertension. Arterial Hypertension. 2015; 19(2): 53–83.
  10. van Loon JE, de Maat MPM, Deckers JW, et al. Prognostic markers in young patients with premature coronary heart disease. Atherosclerosis. 2012; 224(1): 213–217.
  11. Doryńska A, Polak M, Kozela M, et al. Cardiovascular disease (CVD) risk factors in Kraków and in the whole Poland adult population. Results from the WOBASZ study and Polish arm of the HAPIEE project. Przegl Epidemiol. 2015; 69(1): 79–86, 175.
  12. Gordon T, Castelli W, Hjortland M, et al. High density lipoprotein as a protective factor against coronary heart disease. Am J Med. 1977; 62(5): 707–714.
  13. Nowotwory złośliwe ogółem. http://onkologia.org.pl/nowotwory-zlosliwe-ogolem-2/ (05.05.2018).
  14. Craig WY, Palomaki GE, Haddow JE. Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ. 1989; 298(6676): 784–788.
  15. US Surgeon General. The health benefits of smoking cessation. A report of the Surgeon General: US Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion. Rockville, Maryland: Office on Smoking and Health. DHHS 1990: Publication No. (CDC) 90–8416.
  16. Panagiotakos DB, Pitsavos C, Chrysohoou C, et al. Physical activity, high density lipoprotein cholesterol and other lipids levels, in men and women from the ATTICA study. Lipids Health Dis. 2003; 2(8): 3–539.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl